| Aclarubicin (Aclacinomycin A) is an anthracycline antibiotic. It is used in the treatment of cancer. Aclarubicin A, an anthracycline drug, specific inhibitor of the 20S proteasome chymotrypsin-like activity. Synonyms: (1R,2R,4S)-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester, [1R-(1alpha,2beta,4beta)]-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester, Aclacinomycin A, Aclacur, Antibiotic 3082A, Antibiotic 77-3082A, Antibiotic MA 144A1, Jaclacin, NSC 208734 CAS No: 57576-44-0 Molecular Formula: C42H53NO15 Molecular Weight: 811.87 Purity: 98% Appearance: Dark yellow to dark orange solid Melting Point: >127C (dec.) (lit) Storage and Stability: Store at -20C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. |
